#  @vtcarguy81 GreenMtnTrader GreenMtnTrader posts on X about $vktx, $mdgl, acquisition, $nvo the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours. ### Engagements: [---] [#](/creator/twitter::1355204684/interactions)  - [--] Week [-----] +151% - [--] Month [-----] +226% - [--] Months [------] +113% - [--] Year [------] +79% ### Mentions: [--] [#](/creator/twitter::1355204684/posts_active)  - [--] Months [--] +63% - [--] Year [--] -41% ### Followers: [---] [#](/creator/twitter::1355204684/followers)  - [--] Week [---] +1.10% - [--] Month [---] +2% - [--] Months [---] +2.60% - [--] Year [---] +12% ### CreatorRank: [---------] [#](/creator/twitter::1355204684/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) [stocks](/list/stocks) [cryptocurrencies](/list/cryptocurrencies) [technology brands](/list/technology-brands) [us election](/list/us-election) [currencies](/list/currencies) [celebrities](/list/celebrities) [countries](/list/countries) **Social topic influence** [$vktx](/topic/$vktx) #35, [$mdgl](/topic/$mdgl), [acquisition](/topic/acquisition), [$nvo](/topic/$nvo), [$lly](/topic/$lly), [based](/topic/based), [$gpcr](/topic/$gpcr), [biotech](/topic/biotech), [$iova](/topic/$iova), [$imgn](/topic/$imgn) **Top accounts mentioned or mentioned by** [@pharmdca](/creator/undefined) [@andreagtc](/creator/undefined) [@bioinvestor24](/creator/undefined) [@biohazard3737](/creator/undefined) [@gilamonstrum](/creator/undefined) [@healthcareninj1](/creator/undefined) [@wallstsai](/creator/undefined) [@persimmonti](/creator/undefined) [@sportsbios](/creator/undefined) [@researchpulse1](/creator/undefined) [@idomeneusog](/creator/undefined) [@lipa0902](/creator/undefined) [@vinnyjay87](/creator/undefined) [@dreesenkl](/creator/undefined) [@tedbrogan5](/creator/undefined) [@craigster771](/creator/undefined) [@lilienfeld1](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@marionawfal](/creator/undefined) [@ipodave](/creator/undefined) **Top assets mentioned** [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly) [Structure Therapeutics Inc. (GPCR)](/topic/$gpcr) [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) [Immunogen Inc (IMGN)](/topic/$imgn) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Metsera, Inc. (MTSR)](/topic/$mtsr) [HoDooi (HOD)](/topic/$hod) [Goldman Sachs (GS)](/topic/goldman-sachs) [Alphabet Inc Class A (GOOGL)](/topic/$googl) [Sanofi (SNY)](/topic/sanofi) [Akropolis (AKRO)](/topic/$akro) [Amgen, Inc. (AMGN)](/topic/$amgn) [Johnson & Johnson (JNJ)](/topic/$jnj) [AstraZeneca PLC (AZN)](/topic/$azn) [8B People vs [-----] Billionaires (8B)](/topic/$8b) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Cymabay Therapeutics (CBAY)](/topic/$cbay) [Immunovant, Inc. Common Stock (IMVT)](/topic/$imvt) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Terns Pharmaceuticals, Inc. (TERN)](/topic/$tern) [AltLayer (ALT)](/topic/$alt) [Viking Holdings Ltd (VIK)](/topic/$vik) [Inari Medical, Inc. (NARI)](/topic/$nari) [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Karuna Therapeutics, Inc. Common Stock (KRTX)](/topic/$krtx) [Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP)](/topic/$hznp) [IVERIC bio, Inc. Common Stock (ISEE)](/topic/$isee) [BlueCoin (BLU)](/topic/$blu) ### Top Social Posts Top posts by engagements in the last [--] hours "$mdgl Madrigal Pharmaceuticals price target raised to $390 from $312 at JMP Securities" [X Link](https://x.com/vtcarguy81/status/1611363381226651649) 2023-01-06T14:05Z [---] followers, [--] engagements "@Dreesenkl Paulson and his company specialize in event driven investments - i.e. in mergers acquisitions spin offs proxy contests etc" [X Link](https://x.com/vtcarguy81/status/1691834072782233710) 2023-08-16T15:27Z [---] followers, [---] engagements "@TedBrogan5 @Andre_AGTC @Craigster771 For F1 GLp 1s are fine but since they havent proven to help with fibrosis F2 F3 and potentially F4 would be candidates for Resmetirom" [X Link](https://x.com/vtcarguy81/status/1702497200247361930) 2023-09-15T01:38Z [---] followers, [--] engagements "$MDGL Tute ownership at all time highs. As price decreased ownership increased" [X Link](https://x.com/vtcarguy81/status/1707085033972859024) 2023-09-27T17:29Z [---] followers, [----] engagements "FDA updates Ozempic label to acknowledge some users reports of blocked intestines CNN $MDGL" [X Link](https://x.com/vtcarguy81/status/1707442603015254463) 2023-09-28T17:10Z [---] followers, [---] engagements "$ICPT was bought for $800M with one drug for Biliary Cholangitis which has a projected market of $1.36B by [----]. NASH market projected to be 15-20X that. No wonder $MDGL J Baker and the board may have turned down $6B (assumption based on $310 closing price earlier in the year)" [X Link](https://x.com/anyuser/status/1708218377007935916) 2023-09-30T20:32Z [--] followers, [----] engagements "@HealthcareNinj1 nice work. I will point out that H Waxman patent ext is listed as [--] yrs there is add [--] mo stay preventing fda from appving gen comp tech prvding [---] years of exclusivity on the market. B Taub has publically stated they plan on hanging h waxman extension on [--] polymorph patent" [X Link](https://x.com/vtcarguy81/status/1708512860832440526) 2023-10-01T16:03Z [---] followers, [---] engagements "@lilienfeld1 @WallStSai @BowTiedBiotech" [X Link](https://x.com/vtcarguy81/status/1713664574560366894) 2023-10-15T21:14Z [---] followers, [---] engagements "What will get the best return (L) in the next [--] days $IOVA $IMGN $MDGL @Pharmdca $hod @Biohazard3737" [X Link](https://x.com/vtcarguy81/status/1726295407397929469) 2023-11-19T17:44Z [---] followers, [---] engagements "$IOVA Goldman Sachs PT $12" [X Link](https://x.com/vtcarguy81/status/1726635794092404908) 2023-11-20T16:17Z [---] followers, [---] engagements "$IMGN Congrats longs My 2nd buyout since I started trading bios in [----]. Today was a good day" [X Link](https://x.com/vtcarguy81/status/1730397169176223751) 2023-12-01T01:23Z [---] followers, [---] engagements "@MarioNawfal Looks like a screen grab of google earth" [X Link](https://x.com/vtcarguy81/status/1732024789387092457) 2023-12-05T13:11Z [---] followers, [--] engagements "Poison centers see nearly 1500% increase in calls related to injected weight-loss drugs as people accidentally overdose CNN $LLY $NVO $MDGL $ $VKTX" [X Link](https://x.com/vtcarguy81/status/1736584483124412613) 2023-12-18T03:09Z [---] followers, [---] engagements "@IPODave Roche Merck LLY NVO Sanofi" [X Link](https://x.com/vtcarguy81/status/1738208932949000432) 2023-12-22T14:44Z [---] followers, [--] engagements "$MDGL $AKRO $VKTX $LLY $NVO Now out this week in their quarterly report @US_FDA confirms it is "evaluating the need for regulatory action" after reports in patients taking GLP-1 medications like Ozempic and Wegovy of alopecia aspiration suicidal ideation https://t.co/R5dXANP9RS https://t.co/DCegJG6CjK Now out this week in their quarterly report @US_FDA confirms it is "evaluating the need for regulatory action" after reports in patients taking GLP-1 medications like Ozempic and Wegovy of alopecia aspiration suicidal ideation https://t.co/R5dXANP9RS https://t.co/DCegJG6CjK" [X Link](https://x.com/vtcarguy81/status/1742694568699764753) 2024-01-03T23:48Z [---] followers, [---] engagements "@dot_61 @PersimmonTI Maybe $70 buyout is only a matter of time imo. Will load the boat at those levels if that happens" [X Link](https://x.com/vtcarguy81/status/1744128707151777942) 2024-01-07T22:47Z [---] followers, [---] engagements "@HawkishSkip $CYTK acquisition news" [X Link](https://x.com/anyuser/status/1744474662178857169) 2024-01-08T21:42Z [--] followers, [---] engagements "@msp12389 @Sports_bios [--] suitors" [X Link](https://x.com/vtcarguy81/status/1745642844482637985) 2024-01-12T03:04Z [---] followers, [---] engagements "@Biotech_SD Congrats Mom 😉" [X Link](https://x.com/vtcarguy81/status/1747781012707328157) 2024-01-18T00:40Z [---] followers, [--] engagements "@WallStSai @Malsonian What did XBI do today" [X Link](https://x.com/vtcarguy81/status/1748119691959124438) 2024-01-18T23:06Z [---] followers, [---] engagements "@SnackBioTech I think we are past an Adcom announcement" [X Link](https://x.com/vtcarguy81/status/1750330920224059753) 2024-01-25T01:33Z [---] followers, [---] engagements "$IOVA After hours 👀" [X Link](https://x.com/anyuser/status/1750675988512420202) 2024-01-26T00:24Z [--] followers, [---] engagements "@PCM_bio @OxAnalyst Never mind that was the chief commercial officer" [X Link](https://x.com/vtcarguy81/status/1753610340699345007) 2024-02-03T02:44Z [---] followers, [--] engagements "@murphycpr $CYTK $JNJ $AMGN $AZN" [X Link](https://x.com/vtcarguy81/status/1754656938174878106) 2024-02-06T00:03Z [---] followers, [---] engagements "$MDGL $LLY I don't care how long they have had access to SYNERGY data. I believe if there was statistical significance to fibrosis improvement they would have shared it at earnings. BP playing games IMO" [X Link](https://x.com/vtcarguy81/status/1754908184437772376) 2024-02-06T16:41Z [---] followers, [----] engagements "UBS analyst Eliana Merle keeps a Buy on $MDGL Madrigal Pharmaceuticals with a $337 PT after hosting a physician call with an academic hepatologist to go over the metabolic dysfunction-associated steatohepatitis commercial and treatment landscapes. https://www.tipranks.com/news/the-fly/ubs-physician-call-supports-significant-mash-opportunity-for-madrigal https://www.tipranks.com/news/the-fly/ubs-physician-call-supports-significant-mash-opportunity-for-madrigal" [X Link](https://x.com/vtcarguy81/status/1755475383422435762) 2024-02-08T06:15Z [---] followers, [---] engagements "$MDGL A very realistic scenario for acquisition IMO [-----] patients x $25000 Net = $2B/Yr Peak Sales $2B x [--] = $8B $8B / 21M shares (estimate) = $380 PT" [X Link](https://x.com/vtcarguy81/status/1757073541604774358) 2024-02-12T16:05Z [---] followers, [----] engagements "$MDGL does anybody know how much firepower $GILD would have remaining after the $CBAY acquisition" [X Link](https://x.com/vtcarguy81/status/1757094231590486183) 2024-02-12T17:28Z [---] followers, [----] engagements "@TOWiU2 @jonesallen236 @Pharmdca Your portfolio is looking good 👍🏼" [X Link](https://x.com/vtcarguy81/status/1763683611016876246) 2024-03-01T21:51Z [---] followers, [--] engagements "$MDGL Looks like accumulation" [X Link](https://x.com/vtcarguy81/status/1773335590240403788) 2024-03-28T13:05Z [---] followers, [---] engagements "@0xPasserby @bio_report Basically the same day BOFA analyst says theyll have trouble with payers we find out best case coverage with $UNH" [X Link](https://x.com/vtcarguy81/status/1784451074591506442) 2024-04-28T05:14Z [---] followers, [--] engagements "$IMVT - Samantha Semenkow an analyst from Citi maintained the Buy rating on Immunovant (IMVT Research Report). The associated price target is $51.00" [X Link](https://x.com/vtcarguy81/status/1796175274582684015) 2024-05-30T13:42Z [---] followers, [---] engagements "$MDGL Looking strong 💪🏼" [X Link](https://x.com/vtcarguy81/status/1799497220074459378) 2024-06-08T17:42Z [---] followers, [---] engagements "Does $XBI sniff a major acquisition pending" [X Link](https://x.com/vtcarguy81/status/1800599496126288207) 2024-06-11T18:42Z [---] followers, [---] engagements "@stockassassin74 @Sports_bios Paul Friedman with previous ties to Merck. Sanofi could be another top contender for partnership or acquisition IMO" [X Link](https://x.com/vtcarguy81/status/1802369860954939794) 2024-06-16T15:57Z [---] followers, [---] engagements "@JNap5C Are you not concerned about bone density issues" [X Link](https://x.com/vtcarguy81/status/1825991226778153188) 2024-08-20T20:20Z [---] followers, [--] engagements "@pnani456 I cant help but think about generic Ozempic and how that might dampen sales once Vikings products get to market" [X Link](https://x.com/vtcarguy81/status/1828474545076109764) 2024-08-27T16:47Z [---] followers, [--] engagements "$NVDA quite the increase in short interest" [X Link](https://x.com/vtcarguy81/status/1828989513680499066) 2024-08-29T02:54Z [---] followers, [---] engagements "$MDGL Insightful conversation with management at RTW Investment biotech specialist fund whos largest position is $MDGL https://podcasts.apple.com/us/podcast/business-breakdowns/id1559120677i=1000670913080 https://podcasts.apple.com/us/podcast/business-breakdowns/id1559120677i=1000670913080" [X Link](https://x.com/vtcarguy81/status/1840126545525965309) 2024-09-28T20:28Z [---] followers, [----] engagements "$MDGL Buy Rating on Madrigal Pharmaceuticals: Rezdiffras Rising Prescription Rates and Blockbuster Potential Drive Positive Outlook JMP Securities analyst reiterated a Buy rating on Madrigal Pharmaceuticals today and set a price target of $415.00" [X Link](https://x.com/vtcarguy81/status/1843328243681911039) 2024-10-07T16:31Z [---] followers, [---] engagements "$MDGL Becky Taub Our confidence in the MAESTRO OUTCOMES study is grounded in the antifibrotic profile of res as a liver-directed THR- agonist and supported by positive 52-week data from [---] patients with compensated NASH cirrhosis studied in the Phase [--] MAESTRO-NAFLD-1 study" [X Link](https://x.com/vtcarguy81/status/1848361837592551840) 2024-10-21T13:52Z [---] followers, [---] engagements "$MDGL seeing indications of fairly strong accumulation going into earnings" [X Link](https://x.com/vtcarguy81/status/1850269390081556936) 2024-10-26T20:12Z [---] followers, [----] engagements "@Andre_AGTC Any favorites for potential 10x investments" [X Link](https://x.com/vtcarguy81/status/1850558521412112462) 2024-10-27T15:21Z [---] followers, [---] engagements "$MDGL Price is Right. Rezdiffra Q3 sales is going to be : @Pharmdca @Andre_AGTC @Biohazard3737 $20M - $30M $31M - $40M $50M + $41M - $50M $20M - $30M $31M - $40M $50M + $41M - $50M" [X Link](https://x.com/vtcarguy81/status/1851800273078943833) 2024-10-31T01:36Z [---] followers, [---] engagements "$NVO $MDGL $AKRO Pretty vague press release for a Phase [--] NASH/MASH trial" [X Link](https://x.com/vtcarguy81/status/1852340214665990310) 2024-11-01T13:21Z [---] followers, [---] engagements "@GilaMonstrum Do we know if this is ITT" [X Link](https://x.com/vtcarguy81/status/1852352488462024983) 2024-11-01T14:10Z [---] followers, [--] engagements "@M_MJM889 @HealthcareNinj1 It's great to see the team executing Glad you found my posts helpful" [X Link](https://x.com/vtcarguy81/status/1852356085828530282) 2024-11-01T14:24Z [---] followers, [---] engagements "$VKTX nice coverage @bioinvestor24 👏🏼" [X Link](https://x.com/vtcarguy81/status/1853250041953296887) 2024-11-04T01:36Z [---] followers, [---] engagements "$VKTK where does this trade 24hrs" [X Link](https://x.com/vtcarguy81/status/1853254098159599982) 2024-11-04T01:53Z [---] followers, [---] engagements "$vktx some healthy volume today looks like it could be some stealthy short covering" [X Link](https://x.com/vtcarguy81/status/1853898004018696409) 2024-11-05T20:31Z [---] followers, [---] engagements "@BullTradeFinder @elonmusk @diana_dukic How is that not true Please explain" [X Link](https://x.com/vtcarguy81/status/1858246389802926086) 2024-11-17T20:30Z [---] followers, [--] engagements "How are we liking $AKRO $XBI at $29" [X Link](https://x.com/vtcarguy81/status/1858638004157288479) 2024-11-18T22:26Z [---] followers, [---] engagements "$XBI "Make America Healthy Again"" [X Link](https://x.com/vtcarguy81/status/1858658529210507542) 2024-11-18T23:48Z [---] followers, [---] engagements "@VivekGRamaswamy @VivekGRamaswamy please keep RFK far away from the FDA" [X Link](https://x.com/vtcarguy81/status/1858705290159346074) 2024-11-19T02:54Z [---] followers, [--] engagements "@AdamSinger @MBbiotech Come to find out RFK loves him some Mickey Ds" [X Link](https://x.com/vtcarguy81/status/1858732993952555029) 2024-11-19T04:44Z [---] followers, [--] engagements "@Biohazard3737 Sometimes you need to let people save face sounds like this is what the Colombian president was attempting to do. Well see how this shakes out I suppose" [X Link](https://x.com/vtcarguy81/status/1883676561356009661) 2025-01-27T00:41Z [---] followers, [--] engagements "$VKTX Bullish divergence" [X Link](https://x.com/vtcarguy81/status/1893437982394261537) 2025-02-22T23:09Z [---] followers, [----] engagements "$VKTX $20-$40B doesnt sound so bad" [X Link](https://x.com/vtcarguy81/status/1899578872053604608) 2025-03-11T21:51Z [---] followers, [---] engagements "@PJamess69 Fully diluted market cap sits at roughly $10B. Whats a realistic buyout amount" [X Link](https://x.com/vtcarguy81/status/1902658672372666770) 2025-03-20T09:49Z [---] followers, [--] engagements "$VKTX $NVO $LLY $MTSR $GPCR $TERN" [X Link](https://x.com/vtcarguy81/status/1959281759234797850) 2025-08-23T15:49Z [---] followers, [---] engagements "$VKTX Acceptance of liver stiffness endpoint: In late August [----] the FDA accepted a proposal for a noninvasive biomarker for liver stiffness to be used as a reasonably likely surrogate endpoint for mortality or liver-related events in MASH clinical trials" [X Link](https://x.com/vtcarguy81/status/1960762173635928510) 2025-08-27T17:51Z [---] followers, [----] engagements "@LifeSciAdvisors $icpt $vtkx $mdgl safe well tolerated and effective in previous trials. NASH candidate with accepted IND" [X Link](https://x.com/vtcarguy81/status/1178870024364331008) 2019-10-01T03:11Z [---] followers, [--] engagements "@SCbiotechlover Similar situation to $AIMT bought by Nestle" [X Link](https://x.com/vtcarguy81/status/1356450586967818241) 2021-02-02T03:53Z [---] followers, [--] engagements "$MDGL Q2 [----] Earnings Beat - Sales $14.648M vs 3.903M Estimate - 50% of Lives covered with 5% requiring biopsy - EMA currently under review plans to commercialize Rezdiffra directly in Europe" [X Link](https://x.com/vtcarguy81/status/1821142820175946154) 2024-08-07T11:14Z [---] followers, [----] engagements "@PersimmonTI Im seeing signs of slow accumulation as the price has been drifting and drifting lower. It appears to be a possible reversal forming with accumulation picking up steam. Would go along with a reasonable storyline of stock manipulation with a buyout possible at ATH" [X Link](https://x.com/vtcarguy81/status/1893441630725656866) 2025-02-22T23:23Z [---] followers, [---] engagements "$VKTX I'm not pumping" [X Link](https://x.com/vtcarguy81/status/1897002165195153509) 2025-03-04T19:12Z [---] followers, [----] engagements "$VKTK hypothetically management can buy up the remaining float" [X Link](https://x.com/vtcarguy81/status/1897003948655116592) 2025-03-04T19:19Z [---] followers, [---] engagements "@Mufaso7 @ResearchPulse1 @bioinvestor24 Buy the dip" [X Link](https://x.com/vtcarguy81/status/1987910391209263393) 2025-11-10T15:49Z [---] followers, [--] engagements "@PGainz96934 @pacha_8x Please tell my why $ALT has a $320M market cap and $VKTX is at $4.5B" [X Link](https://x.com/vtcarguy81/status/1988409641341231162) 2025-11-12T00:52Z [---] followers, [---] engagements "$VKTX Canaccord views Viking as a highly appealing asset in the obesity space and the leading biotech asset in obesity clinical development" [X Link](https://x.com/vtcarguy81/status/1988982057255723510) 2025-11-13T14:47Z [---] followers, [---] engagements "@Pharmdca @Pharmdca I believe at some point you also mentioned what you dont like $ALTs obesity drug" [X Link](https://x.com/vtcarguy81/status/1989081367788023990) 2025-11-13T21:22Z [---] followers, [---] engagements "The Baker boys are back $VKTX" [X Link](https://x.com/anyuser/status/1989565813922095327) 2025-11-15T05:27Z [---] followers, [----] engagements "$VKTX What will happen if a Baker Brother joins the board" [X Link](https://x.com/anyuser/status/1993075595719459191) 2025-11-24T21:53Z [---] followers, [---] engagements "@Andre_AGTC Full diluted market cap put $MDGL at over $17B currently" [X Link](https://x.com/vtcarguy81/status/1993158627742695434) 2025-11-25T03:23Z [---] followers, [--] engagements "@troutandchar @Pharmdca Until it goes to $100" [X Link](https://x.com/vtcarguy81/status/1996693386800349309) 2025-12-04T21:29Z [---] followers, [--] engagements "H.C. Wainwright bullish on Viking Therapeutics ($VKTX) after Lillys positive Phase [--] data for oral obesity drug. Maintains Buy rating with $102 PT. #Biotech #Obesity #VKTX #LLY" [X Link](https://x.com/anyuser/status/2002081441807794283) 2025-12-19T18:19Z [---] followers, [---] engagements "$VKTX Something feels odd about timing of Forbes article JPM conference and 10% haircut" [X Link](https://x.com/anyuser/status/2008281387518788018) 2026-01-05T20:56Z [---] followers, [----] engagements "@princetongb Is the spread between GPCR and VKTX right now because of perceived better margins and easier manufacturing of GPCR small molecule" [X Link](https://x.com/vtcarguy81/status/2011142898306466253) 2026-01-13T18:26Z [---] followers, [----] engagements "$VKTX Appetite for weight-loss deals broader than visible Viking CEO says https://www.reuters.com/business/healthcare-pharmaceuticals/appetite-weight-loss-deals-broader-than-visible-viking-ceo-says-2026-01-13/ https://www.reuters.com/business/healthcare-pharmaceuticals/appetite-weight-loss-deals-broader-than-visible-viking-ceo-says-2026-01-13/" [X Link](https://x.com/anyuser/status/2011198113592263101) 2026-01-13T22:06Z [---] followers, [---] engagements "$VKTX one M&A mention away from a massive squeeze Shorts on borrowed time" [X Link](https://x.com/anyuser/status/2011517091090956624) 2026-01-14T19:13Z [---] followers, [---] engagements "@prosperousguy @CNBCFastMoney Same group that said VKTX would be bought out after phase [--] subcutaneous" [X Link](https://x.com/vtcarguy81/status/2013771179488666006) 2026-01-21T00:30Z [---] followers, [--] engagements "$VKTX @Idomeneus_OG @GilaMonstrum @lipa0902 Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change with a strict post-dose cutoff @Idomeneus_OG @GilaMonstrum @lipa0902 Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change" [X Link](https://x.com/anyuser/status/2014492240442261801) 2026-01-23T00:15Z [---] followers, [---] engagements "@TraderIndus @Pharmdca For every $PAVM and $PDSB hes got $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP" [X Link](https://x.com/vtcarguy81/status/1987381296239095891) 2025-11-09T04:46Z [---] followers, [---] engagements "$GPCR Let me guess buyout at $95" [X Link](https://x.com/vtcarguy81/status/2014346268831625562) 2026-01-22T14:35Z [---] followers, [---] engagements "@Biotech_Investr @semodough @Pharmdca 24.34M shares short" [X Link](https://x.com/vtcarguy81/status/2015789038549061861) 2026-01-26T14:08Z [---] followers, [---] engagements "$VKTX announced plans to advance their sub VK2735 directly from Ph2 to Ph3 skipping a Phase 2b trial. This decision was discussed during their Q2 [--] earnings call (July 24) BL indicated they would bypass Ph2b and proceed to Ph3 based on strong Ph2 VENTURE study results" [X Link](https://x.com/anyuser/status/2015997638831669504) 2026-01-27T03:57Z [---] followers, [---] engagements "@predictflo @donaldjdean How much $ betting for a buyout" [X Link](https://x.com/vtcarguy81/status/2016232811359830139) 2026-01-27T19:32Z [---] followers, [--] engagements "VKTX oral VK2735 could get a streamlined Phase [--] boost from the maintenance study (oral arms post-subq induction). Sustained weight control + bridging data might let them leverage subq VANQUISH safety/eff for faster oral path. Mid-2026 readout key #Biotech $VKTX" [X Link](https://x.com/anyuser/status/2018030253864538254) 2026-02-01T18:34Z [---] followers, [----] engagements "@BatScientist Are you a hedge fund I don't get it" [X Link](https://x.com/vtcarguy81/status/2018745987053822463) 2026-02-03T17:58Z [---] followers, [--] engagements "@SpacGuru $MTSR was down 30% from recent highs when acquisition was first leaked you never know" [X Link](https://x.com/vtcarguy81/status/2019069165089267934) 2026-02-04T15:22Z [---] followers, [--] engagements "@VinnyJay87 @bioinvestor24 Triple agonists like retatrutide cause modest HR rise (510 bpm) usually transient/mild. Not ideal for patients with heart issues" [X Link](https://x.com/vtcarguy81/status/2020227739375010065) 2026-02-07T20:06Z [---] followers, [--] engagements "@ResearchPulse1 @apotecarii @bioinvestor24 @JacobCordosa Annual sales potential at full capacity: [----] million patients $2400 $15.8 billion per year" [X Link](https://x.com/vtcarguy81/status/2020596942594830794) 2026-02-08T20:33Z [---] followers, [---] engagements "$VKTX time to squeeze these 🐻s they deserve everything theyve got coming to them" [X Link](https://x.com/anyuser/status/2022322435723296832) 2026-02-13T14:50Z [---] followers, [---] engagements "$VKTX It's always darkest before the dawn. I went through the same thing in $MDGL" [X Link](https://x.com/vtcarguy81/status/2016568725235728831) 2026-01-28T17:47Z [---] followers, [---] engagements "$VKTX I dont see how any type of credible rumor doesnt catapult this stock to $85 per share min" [X Link](https://x.com/anyuser/status/2022742169522676195) 2026-02-14T18:38Z [---] followers, [----] engagements "$VKTX I dont see how any type of credible rumor doesnt catapult this stock to $85 per share min" [X Link](https://x.com/anyuser/status/2022742169522676195) 2026-02-14T18:38Z [---] followers, [----] engagements "$VKTX time to squeeze these 🐻s they deserve everything theyve got coming to them" [X Link](https://x.com/anyuser/status/2022322435723296832) 2026-02-13T14:50Z [---] followers, [---] engagements "$VKTX finally emerging from the data desert since p2 oral. Great time to go long imo" [X Link](https://x.com/anyuser/status/2021389180530811296) 2026-02-11T01:01Z [---] followers, [---] engagements "$XBI HIMS taking down the whole bio sector @WhiteHouse" [X Link](https://x.com/anyuser/status/2019497903924953137) 2026-02-05T19:46Z [---] followers, [---] engagements "VKTX oral VK2735 could get a streamlined Phase [--] boost from the maintenance study (oral arms post-subq induction). Sustained weight control + bridging data might let them leverage subq VANQUISH safety/eff for faster oral path. Mid-2026 readout key #Biotech $VKTX" [X Link](https://x.com/anyuser/status/2018030253864538254) 2026-02-01T18:34Z [---] followers, [----] engagements "$LLY $NVO $VKTX $GPCR Rates of obesity among U.S. adults doubled in [--] decades https://www.yahoo.com/news/articles/analysis-rates-obesity-among-u-181219148.html https://www.yahoo.com/news/articles/analysis-rates-obesity-among-u-181219148.html" [X Link](https://x.com/anyuser/status/2016581383276101703) 2026-01-28T18:37Z [---] followers, [---] engagements "$VKTX It's always darkest before the dawn. I went through the same thing in $MDGL" [X Link](https://x.com/vtcarguy81/status/2016568725235728831) 2026-01-28T17:47Z [---] followers, [---] engagements "$VKTX announced plans to advance their sub VK2735 directly from Ph2 to Ph3 skipping a Phase 2b trial. This decision was discussed during their Q2 [--] earnings call (July 24) BL indicated they would bypass Ph2b and proceed to Ph3 based on strong Ph2 VENTURE study results" [X Link](https://x.com/anyuser/status/2015997638831669504) 2026-01-27T03:57Z [---] followers, [---] engagements "$VKTX @Idomeneus_OG @GilaMonstrum @lipa0902 Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change with a strict post-dose cutoff @Idomeneus_OG @GilaMonstrum @lipa0902 Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change" [X Link](https://x.com/anyuser/status/2014492240442261801) 2026-01-23T00:15Z [---] followers, [---] engagements "Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change with a strict post-dose cutoff (9+ days). - Lilly (Tirzepatide SURMOUNT): Used MMRM for efficacy estimand reporting LSM; MI/RD-MI for hybrid estimand with missing data. - Novo (Semaglutide STEP): Used ANCOVA with RD-MI for primary; MMRM for secondary reporting LSM. Their cutoff is last dose +14 days. Noumena is correctLSM is common not unique to Viking." [X Link](https://x.com/anyuser/status/2012250358169416003) 2026-01-16T19:47Z 8M followers, [----] engagements "$GPCR Let me guess buyout at $95" [X Link](https://x.com/vtcarguy81/status/2014346268831625562) 2026-01-22T14:35Z [---] followers, [---] engagements "$VKTX one M&A mention away from a massive squeeze Shorts on borrowed time" [X Link](https://x.com/anyuser/status/2011517091090956624) 2026-01-14T19:13Z [---] followers, [---] engagements "$VKTX Appetite for weight-loss deals broader than visible Viking CEO says https://www.reuters.com/business/healthcare-pharmaceuticals/appetite-weight-loss-deals-broader-than-visible-viking-ceo-says-2026-01-13/ https://www.reuters.com/business/healthcare-pharmaceuticals/appetite-weight-loss-deals-broader-than-visible-viking-ceo-says-2026-01-13/" [X Link](https://x.com/anyuser/status/2011198113592263101) 2026-01-13T22:06Z [---] followers, [---] engagements "$VKTX Viking enlists commercial chief to battle obesity giants https://www.fiercepharma.com/marketing/viking-enlists-commercial-chief-battle-obesity-giants https://www.fiercepharma.com/marketing/viking-enlists-commercial-chief-battle-obesity-giants" [X Link](https://x.com/anyuser/status/2009108195046998306) 2026-01-08T03:41Z [---] followers, [---] engagements "$VKTX IMO shorts are on borrowed time. Matter of when not if" [X Link](https://x.com/anyuser/status/2008940514091946264) 2026-01-07T16:35Z [---] followers, [---] engagements "$VKTX Something feels odd about timing of Forbes article JPM conference and 10% haircut" [X Link](https://x.com/anyuser/status/2008281387518788018) 2026-01-05T20:56Z [---] followers, [----] engagements "H.C. Wainwright bullish on Viking Therapeutics ($VKTX) after Lillys positive Phase [--] data for oral obesity drug. Maintains Buy rating with $102 PT. #Biotech #Obesity #VKTX #LLY" [X Link](https://x.com/anyuser/status/2002081441807794283) 2025-12-19T18:19Z [---] followers, [---] engagements "$VKTX What will happen if a Baker Brother joins the board" [X Link](https://x.com/anyuser/status/1993075595719459191) 2025-11-24T21:53Z [---] followers, [---] engagements "The Baker boys are back $VKTX" [X Link](https://x.com/anyuser/status/1989565813922095327) 2025-11-15T05:27Z [---] followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@vtcarguy81 GreenMtnTraderGreenMtnTrader posts on X about $vktx, $mdgl, acquisition, $nvo the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
Social category influence finance stocks cryptocurrencies technology brands us election currencies celebrities countries
Social topic influence $vktx #35, $mdgl, acquisition, $nvo, $lly, based, $gpcr, biotech, $iova, $imgn
Top accounts mentioned or mentioned by @pharmdca @andreagtc @bioinvestor24 @biohazard3737 @gilamonstrum @healthcareninj1 @wallstsai @persimmonti @sportsbios @researchpulse1 @idomeneusog @lipa0902 @vinnyjay87 @dreesenkl @tedbrogan5 @craigster771 @lilienfeld1 @bowtiedbiotech @marionawfal @ipodave
Top assets mentioned Viking Therapeutics, Inc (VKTX) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Structure Therapeutics Inc. (GPCR) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Immunogen Inc (IMGN) Cytokinetics Inc. (CYTK) Metsera, Inc. (MTSR) HoDooi (HOD) Goldman Sachs (GS) Alphabet Inc Class A (GOOGL) Sanofi (SNY) Akropolis (AKRO) Amgen, Inc. (AMGN) Johnson & Johnson (JNJ) AstraZeneca PLC (AZN) 8B People vs [-----] Billionaires (8B) Gilead Sciences, Inc. (GILD) Cymabay Therapeutics (CBAY) Immunovant, Inc. Common Stock (IMVT) NVIDIA Corp. (NVDA) Terns Pharmaceuticals, Inc. (TERN) AltLayer (ALT) Viking Holdings Ltd (VIK) Inari Medical, Inc. (NARI) Blueprint Medicines Corporation (BPMC) Karuna Therapeutics, Inc. Common Stock (KRTX) Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) IVERIC bio, Inc. Common Stock (ISEE) BlueCoin (BLU)
Top posts by engagements in the last [--] hours
"$mdgl Madrigal Pharmaceuticals price target raised to $390 from $312 at JMP Securities"
X Link 2023-01-06T14:05Z [---] followers, [--] engagements
"@Dreesenkl Paulson and his company specialize in event driven investments - i.e. in mergers acquisitions spin offs proxy contests etc"
X Link 2023-08-16T15:27Z [---] followers, [---] engagements
"@TedBrogan5 @Andre_AGTC @Craigster771 For F1 GLp 1s are fine but since they havent proven to help with fibrosis F2 F3 and potentially F4 would be candidates for Resmetirom"
X Link 2023-09-15T01:38Z [---] followers, [--] engagements
"$MDGL Tute ownership at all time highs. As price decreased ownership increased"
X Link 2023-09-27T17:29Z [---] followers, [----] engagements
"FDA updates Ozempic label to acknowledge some users reports of blocked intestines CNN $MDGL"
X Link 2023-09-28T17:10Z [---] followers, [---] engagements
"$ICPT was bought for $800M with one drug for Biliary Cholangitis which has a projected market of $1.36B by [----]. NASH market projected to be 15-20X that. No wonder $MDGL J Baker and the board may have turned down $6B (assumption based on $310 closing price earlier in the year)"
X Link 2023-09-30T20:32Z [--] followers, [----] engagements
"@HealthcareNinj1 nice work. I will point out that H Waxman patent ext is listed as [--] yrs there is add [--] mo stay preventing fda from appving gen comp tech prvding [---] years of exclusivity on the market. B Taub has publically stated they plan on hanging h waxman extension on [--] polymorph patent"
X Link 2023-10-01T16:03Z [---] followers, [---] engagements
"@lilienfeld1 @WallStSai @BowTiedBiotech"
X Link 2023-10-15T21:14Z [---] followers, [---] engagements
"What will get the best return (L) in the next [--] days $IOVA $IMGN $MDGL @Pharmdca $hod @Biohazard3737"
X Link 2023-11-19T17:44Z [---] followers, [---] engagements
"$IOVA Goldman Sachs PT $12"
X Link 2023-11-20T16:17Z [---] followers, [---] engagements
"$IMGN Congrats longs My 2nd buyout since I started trading bios in [----]. Today was a good day"
X Link 2023-12-01T01:23Z [---] followers, [---] engagements
"@MarioNawfal Looks like a screen grab of google earth"
X Link 2023-12-05T13:11Z [---] followers, [--] engagements
"Poison centers see nearly 1500% increase in calls related to injected weight-loss drugs as people accidentally overdose CNN $LLY $NVO $MDGL $ $VKTX"
X Link 2023-12-18T03:09Z [---] followers, [---] engagements
"@IPODave Roche Merck LLY NVO Sanofi"
X Link 2023-12-22T14:44Z [---] followers, [--] engagements
"$MDGL $AKRO $VKTX $LLY $NVO Now out this week in their quarterly report @US_FDA confirms it is "evaluating the need for regulatory action" after reports in patients taking GLP-1 medications like Ozempic and Wegovy of alopecia aspiration suicidal ideation https://t.co/R5dXANP9RS https://t.co/DCegJG6CjK Now out this week in their quarterly report @US_FDA confirms it is "evaluating the need for regulatory action" after reports in patients taking GLP-1 medications like Ozempic and Wegovy of alopecia aspiration suicidal ideation https://t.co/R5dXANP9RS https://t.co/DCegJG6CjK"
X Link 2024-01-03T23:48Z [---] followers, [---] engagements
"@dot_61 @PersimmonTI Maybe $70 buyout is only a matter of time imo. Will load the boat at those levels if that happens"
X Link 2024-01-07T22:47Z [---] followers, [---] engagements
"@HawkishSkip $CYTK acquisition news"
X Link 2024-01-08T21:42Z [--] followers, [---] engagements
"@msp12389 @Sports_bios [--] suitors"
X Link 2024-01-12T03:04Z [---] followers, [---] engagements
"@Biotech_SD Congrats Mom 😉"
X Link 2024-01-18T00:40Z [---] followers, [--] engagements
"@WallStSai @Malsonian What did XBI do today"
X Link 2024-01-18T23:06Z [---] followers, [---] engagements
"@SnackBioTech I think we are past an Adcom announcement"
X Link 2024-01-25T01:33Z [---] followers, [---] engagements
"$IOVA After hours 👀"
X Link 2024-01-26T00:24Z [--] followers, [---] engagements
"@PCM_bio @OxAnalyst Never mind that was the chief commercial officer"
X Link 2024-02-03T02:44Z [---] followers, [--] engagements
"@murphycpr $CYTK $JNJ $AMGN $AZN"
X Link 2024-02-06T00:03Z [---] followers, [---] engagements
"$MDGL $LLY I don't care how long they have had access to SYNERGY data. I believe if there was statistical significance to fibrosis improvement they would have shared it at earnings. BP playing games IMO"
X Link 2024-02-06T16:41Z [---] followers, [----] engagements
"UBS analyst Eliana Merle keeps a Buy on $MDGL Madrigal Pharmaceuticals with a $337 PT after hosting a physician call with an academic hepatologist to go over the metabolic dysfunction-associated steatohepatitis commercial and treatment landscapes. https://www.tipranks.com/news/the-fly/ubs-physician-call-supports-significant-mash-opportunity-for-madrigal https://www.tipranks.com/news/the-fly/ubs-physician-call-supports-significant-mash-opportunity-for-madrigal"
X Link 2024-02-08T06:15Z [---] followers, [---] engagements
"$MDGL A very realistic scenario for acquisition IMO [-----] patients x $25000 Net = $2B/Yr Peak Sales $2B x [--] = $8B $8B / 21M shares (estimate) = $380 PT"
X Link 2024-02-12T16:05Z [---] followers, [----] engagements
"$MDGL does anybody know how much firepower $GILD would have remaining after the $CBAY acquisition"
X Link 2024-02-12T17:28Z [---] followers, [----] engagements
"@TOWiU2 @jonesallen236 @Pharmdca Your portfolio is looking good 👍🏼"
X Link 2024-03-01T21:51Z [---] followers, [--] engagements
"$MDGL Looks like accumulation"
X Link 2024-03-28T13:05Z [---] followers, [---] engagements
"@0xPasserby @bio_report Basically the same day BOFA analyst says theyll have trouble with payers we find out best case coverage with $UNH"
X Link 2024-04-28T05:14Z [---] followers, [--] engagements
"$IMVT - Samantha Semenkow an analyst from Citi maintained the Buy rating on Immunovant (IMVT Research Report). The associated price target is $51.00"
X Link 2024-05-30T13:42Z [---] followers, [---] engagements
"$MDGL Looking strong 💪🏼"
X Link 2024-06-08T17:42Z [---] followers, [---] engagements
"Does $XBI sniff a major acquisition pending"
X Link 2024-06-11T18:42Z [---] followers, [---] engagements
"@stockassassin74 @Sports_bios Paul Friedman with previous ties to Merck. Sanofi could be another top contender for partnership or acquisition IMO"
X Link 2024-06-16T15:57Z [---] followers, [---] engagements
"@JNap5C Are you not concerned about bone density issues"
X Link 2024-08-20T20:20Z [---] followers, [--] engagements
"@pnani456 I cant help but think about generic Ozempic and how that might dampen sales once Vikings products get to market"
X Link 2024-08-27T16:47Z [---] followers, [--] engagements
"$NVDA quite the increase in short interest"
X Link 2024-08-29T02:54Z [---] followers, [---] engagements
"$MDGL Insightful conversation with management at RTW Investment biotech specialist fund whos largest position is $MDGL https://podcasts.apple.com/us/podcast/business-breakdowns/id1559120677i=1000670913080 https://podcasts.apple.com/us/podcast/business-breakdowns/id1559120677i=1000670913080"
X Link 2024-09-28T20:28Z [---] followers, [----] engagements
"$MDGL Buy Rating on Madrigal Pharmaceuticals: Rezdiffras Rising Prescription Rates and Blockbuster Potential Drive Positive Outlook JMP Securities analyst reiterated a Buy rating on Madrigal Pharmaceuticals today and set a price target of $415.00"
X Link 2024-10-07T16:31Z [---] followers, [---] engagements
"$MDGL Becky Taub Our confidence in the MAESTRO OUTCOMES study is grounded in the antifibrotic profile of res as a liver-directed THR- agonist and supported by positive 52-week data from [---] patients with compensated NASH cirrhosis studied in the Phase [--] MAESTRO-NAFLD-1 study"
X Link 2024-10-21T13:52Z [---] followers, [---] engagements
"$MDGL seeing indications of fairly strong accumulation going into earnings"
X Link 2024-10-26T20:12Z [---] followers, [----] engagements
"@Andre_AGTC Any favorites for potential 10x investments"
X Link 2024-10-27T15:21Z [---] followers, [---] engagements
"$MDGL Price is Right. Rezdiffra Q3 sales is going to be : @Pharmdca @Andre_AGTC @Biohazard3737 $20M - $30M $31M - $40M $50M + $41M - $50M $20M - $30M $31M - $40M $50M + $41M - $50M"
X Link 2024-10-31T01:36Z [---] followers, [---] engagements
"$NVO $MDGL $AKRO Pretty vague press release for a Phase [--] NASH/MASH trial"
X Link 2024-11-01T13:21Z [---] followers, [---] engagements
"@GilaMonstrum Do we know if this is ITT"
X Link 2024-11-01T14:10Z [---] followers, [--] engagements
"@M_MJM889 @HealthcareNinj1 It's great to see the team executing Glad you found my posts helpful"
X Link 2024-11-01T14:24Z [---] followers, [---] engagements
"$VKTX nice coverage @bioinvestor24 👏🏼"
X Link 2024-11-04T01:36Z [---] followers, [---] engagements
"$VKTK where does this trade 24hrs"
X Link 2024-11-04T01:53Z [---] followers, [---] engagements
"$vktx some healthy volume today looks like it could be some stealthy short covering"
X Link 2024-11-05T20:31Z [---] followers, [---] engagements
"@BullTradeFinder @elonmusk @diana_dukic How is that not true Please explain"
X Link 2024-11-17T20:30Z [---] followers, [--] engagements
"How are we liking $AKRO $XBI at $29"
X Link 2024-11-18T22:26Z [---] followers, [---] engagements
"$XBI "Make America Healthy Again""
X Link 2024-11-18T23:48Z [---] followers, [---] engagements
"@VivekGRamaswamy @VivekGRamaswamy please keep RFK far away from the FDA"
X Link 2024-11-19T02:54Z [---] followers, [--] engagements
"@AdamSinger @MBbiotech Come to find out RFK loves him some Mickey Ds"
X Link 2024-11-19T04:44Z [---] followers, [--] engagements
"@Biohazard3737 Sometimes you need to let people save face sounds like this is what the Colombian president was attempting to do. Well see how this shakes out I suppose"
X Link 2025-01-27T00:41Z [---] followers, [--] engagements
"$VKTX Bullish divergence"
X Link 2025-02-22T23:09Z [---] followers, [----] engagements
"$VKTX $20-$40B doesnt sound so bad"
X Link 2025-03-11T21:51Z [---] followers, [---] engagements
"@PJamess69 Fully diluted market cap sits at roughly $10B. Whats a realistic buyout amount"
X Link 2025-03-20T09:49Z [---] followers, [--] engagements
"$VKTX $NVO $LLY $MTSR $GPCR $TERN"
X Link 2025-08-23T15:49Z [---] followers, [---] engagements
"$VKTX Acceptance of liver stiffness endpoint: In late August [----] the FDA accepted a proposal for a noninvasive biomarker for liver stiffness to be used as a reasonably likely surrogate endpoint for mortality or liver-related events in MASH clinical trials"
X Link 2025-08-27T17:51Z [---] followers, [----] engagements
"@LifeSciAdvisors $icpt $vtkx $mdgl safe well tolerated and effective in previous trials. NASH candidate with accepted IND"
X Link 2019-10-01T03:11Z [---] followers, [--] engagements
"@SCbiotechlover Similar situation to $AIMT bought by Nestle"
X Link 2021-02-02T03:53Z [---] followers, [--] engagements
"$MDGL Q2 [----] Earnings Beat - Sales $14.648M vs 3.903M Estimate - 50% of Lives covered with 5% requiring biopsy - EMA currently under review plans to commercialize Rezdiffra directly in Europe"
X Link 2024-08-07T11:14Z [---] followers, [----] engagements
"@PersimmonTI Im seeing signs of slow accumulation as the price has been drifting and drifting lower. It appears to be a possible reversal forming with accumulation picking up steam. Would go along with a reasonable storyline of stock manipulation with a buyout possible at ATH"
X Link 2025-02-22T23:23Z [---] followers, [---] engagements
"$VKTX I'm not pumping"
X Link 2025-03-04T19:12Z [---] followers, [----] engagements
"$VKTK hypothetically management can buy up the remaining float"
X Link 2025-03-04T19:19Z [---] followers, [---] engagements
"@Mufaso7 @ResearchPulse1 @bioinvestor24 Buy the dip"
X Link 2025-11-10T15:49Z [---] followers, [--] engagements
"@PGainz96934 @pacha_8x Please tell my why $ALT has a $320M market cap and $VKTX is at $4.5B"
X Link 2025-11-12T00:52Z [---] followers, [---] engagements
"$VKTX Canaccord views Viking as a highly appealing asset in the obesity space and the leading biotech asset in obesity clinical development"
X Link 2025-11-13T14:47Z [---] followers, [---] engagements
"@Pharmdca @Pharmdca I believe at some point you also mentioned what you dont like $ALTs obesity drug"
X Link 2025-11-13T21:22Z [---] followers, [---] engagements
"The Baker boys are back $VKTX"
X Link 2025-11-15T05:27Z [---] followers, [----] engagements
"$VKTX What will happen if a Baker Brother joins the board"
X Link 2025-11-24T21:53Z [---] followers, [---] engagements
"@Andre_AGTC Full diluted market cap put $MDGL at over $17B currently"
X Link 2025-11-25T03:23Z [---] followers, [--] engagements
"@troutandchar @Pharmdca Until it goes to $100"
X Link 2025-12-04T21:29Z [---] followers, [--] engagements
"H.C. Wainwright bullish on Viking Therapeutics ($VKTX) after Lillys positive Phase [--] data for oral obesity drug. Maintains Buy rating with $102 PT. #Biotech #Obesity #VKTX #LLY"
X Link 2025-12-19T18:19Z [---] followers, [---] engagements
"$VKTX Something feels odd about timing of Forbes article JPM conference and 10% haircut"
X Link 2026-01-05T20:56Z [---] followers, [----] engagements
"@princetongb Is the spread between GPCR and VKTX right now because of perceived better margins and easier manufacturing of GPCR small molecule"
X Link 2026-01-13T18:26Z [---] followers, [----] engagements
"$VKTX Appetite for weight-loss deals broader than visible Viking CEO says https://www.reuters.com/business/healthcare-pharmaceuticals/appetite-weight-loss-deals-broader-than-visible-viking-ceo-says-2026-01-13/ https://www.reuters.com/business/healthcare-pharmaceuticals/appetite-weight-loss-deals-broader-than-visible-viking-ceo-says-2026-01-13/"
X Link 2026-01-13T22:06Z [---] followers, [---] engagements
"$VKTX one M&A mention away from a massive squeeze Shorts on borrowed time"
X Link 2026-01-14T19:13Z [---] followers, [---] engagements
"@prosperousguy @CNBCFastMoney Same group that said VKTX would be bought out after phase [--] subcutaneous"
X Link 2026-01-21T00:30Z [---] followers, [--] engagements
"$VKTX @Idomeneus_OG @GilaMonstrum @lipa0902 Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change with a strict post-dose cutoff @Idomeneus_OG @GilaMonstrum @lipa0902 Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change"
X Link 2026-01-23T00:15Z [---] followers, [---] engagements
"@TraderIndus @Pharmdca For every $PAVM and $PDSB hes got $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP"
X Link 2025-11-09T04:46Z [---] followers, [---] engagements
"$GPCR Let me guess buyout at $95"
X Link 2026-01-22T14:35Z [---] followers, [---] engagements
"@Biotech_Investr @semodough @Pharmdca 24.34M shares short"
X Link 2026-01-26T14:08Z [---] followers, [---] engagements
"$VKTX announced plans to advance their sub VK2735 directly from Ph2 to Ph3 skipping a Phase 2b trial. This decision was discussed during their Q2 [--] earnings call (July 24) BL indicated they would bypass Ph2b and proceed to Ph3 based on strong Ph2 VENTURE study results"
X Link 2026-01-27T03:57Z [---] followers, [---] engagements
"@predictflo @donaldjdean How much $ betting for a buyout"
X Link 2026-01-27T19:32Z [---] followers, [--] engagements
"VKTX oral VK2735 could get a streamlined Phase [--] boost from the maintenance study (oral arms post-subq induction). Sustained weight control + bridging data might let them leverage subq VANQUISH safety/eff for faster oral path. Mid-2026 readout key #Biotech $VKTX"
X Link 2026-02-01T18:34Z [---] followers, [----] engagements
"@BatScientist Are you a hedge fund I don't get it"
X Link 2026-02-03T17:58Z [---] followers, [--] engagements
"@SpacGuru $MTSR was down 30% from recent highs when acquisition was first leaked you never know"
X Link 2026-02-04T15:22Z [---] followers, [--] engagements
"@VinnyJay87 @bioinvestor24 Triple agonists like retatrutide cause modest HR rise (510 bpm) usually transient/mild. Not ideal for patients with heart issues"
X Link 2026-02-07T20:06Z [---] followers, [--] engagements
"@ResearchPulse1 @apotecarii @bioinvestor24 @JacobCordosa Annual sales potential at full capacity: [----] million patients $2400 $15.8 billion per year"
X Link 2026-02-08T20:33Z [---] followers, [---] engagements
"$VKTX time to squeeze these 🐻s they deserve everything theyve got coming to them"
X Link 2026-02-13T14:50Z [---] followers, [---] engagements
"$VKTX It's always darkest before the dawn. I went through the same thing in $MDGL"
X Link 2026-01-28T17:47Z [---] followers, [---] engagements
"$VKTX I dont see how any type of credible rumor doesnt catapult this stock to $85 per share min"
X Link 2026-02-14T18:38Z [---] followers, [----] engagements
"$VKTX I dont see how any type of credible rumor doesnt catapult this stock to $85 per share min"
X Link 2026-02-14T18:38Z [---] followers, [----] engagements
"$VKTX time to squeeze these 🐻s they deserve everything theyve got coming to them"
X Link 2026-02-13T14:50Z [---] followers, [---] engagements
"$VKTX finally emerging from the data desert since p2 oral. Great time to go long imo"
X Link 2026-02-11T01:01Z [---] followers, [---] engagements
"$XBI HIMS taking down the whole bio sector @WhiteHouse"
X Link 2026-02-05T19:46Z [---] followers, [---] engagements
"VKTX oral VK2735 could get a streamlined Phase [--] boost from the maintenance study (oral arms post-subq induction). Sustained weight control + bridging data might let them leverage subq VANQUISH safety/eff for faster oral path. Mid-2026 readout key #Biotech $VKTX"
X Link 2026-02-01T18:34Z [---] followers, [----] engagements
"$LLY $NVO $VKTX $GPCR Rates of obesity among U.S. adults doubled in [--] decades https://www.yahoo.com/news/articles/analysis-rates-obesity-among-u-181219148.html https://www.yahoo.com/news/articles/analysis-rates-obesity-among-u-181219148.html"
X Link 2026-01-28T18:37Z [---] followers, [---] engagements
"$VKTX It's always darkest before the dawn. I went through the same thing in $MDGL"
X Link 2026-01-28T17:47Z [---] followers, [---] engagements
"$VKTX announced plans to advance their sub VK2735 directly from Ph2 to Ph3 skipping a Phase 2b trial. This decision was discussed during their Q2 [--] earnings call (July 24) BL indicated they would bypass Ph2b and proceed to Ph3 based on strong Ph2 VENTURE study results"
X Link 2026-01-27T03:57Z [---] followers, [---] engagements
"$VKTX @Idomeneus_OG @GilaMonstrum @lipa0902 Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change with a strict post-dose cutoff @Idomeneus_OG @GilaMonstrum @lipa0902 Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change"
X Link 2026-01-23T00:15Z [---] followers, [---] engagements
"Based on trial data: - LSM (least squares means) is a standard output from regression models like MMRM or ANCOVA used across obesity trials to report adjusted weight loss. - Viking (VK2735 VENTURE): Used MMRM to estimate LSM for weight change with a strict post-dose cutoff (9+ days). - Lilly (Tirzepatide SURMOUNT): Used MMRM for efficacy estimand reporting LSM; MI/RD-MI for hybrid estimand with missing data. - Novo (Semaglutide STEP): Used ANCOVA with RD-MI for primary; MMRM for secondary reporting LSM. Their cutoff is last dose +14 days. Noumena is correctLSM is common not unique to Viking."
X Link 2026-01-16T19:47Z 8M followers, [----] engagements
"$GPCR Let me guess buyout at $95"
X Link 2026-01-22T14:35Z [---] followers, [---] engagements
"$VKTX one M&A mention away from a massive squeeze Shorts on borrowed time"
X Link 2026-01-14T19:13Z [---] followers, [---] engagements
"$VKTX Appetite for weight-loss deals broader than visible Viking CEO says https://www.reuters.com/business/healthcare-pharmaceuticals/appetite-weight-loss-deals-broader-than-visible-viking-ceo-says-2026-01-13/ https://www.reuters.com/business/healthcare-pharmaceuticals/appetite-weight-loss-deals-broader-than-visible-viking-ceo-says-2026-01-13/"
X Link 2026-01-13T22:06Z [---] followers, [---] engagements
"$VKTX Viking enlists commercial chief to battle obesity giants https://www.fiercepharma.com/marketing/viking-enlists-commercial-chief-battle-obesity-giants https://www.fiercepharma.com/marketing/viking-enlists-commercial-chief-battle-obesity-giants"
X Link 2026-01-08T03:41Z [---] followers, [---] engagements
"$VKTX IMO shorts are on borrowed time. Matter of when not if"
X Link 2026-01-07T16:35Z [---] followers, [---] engagements
"$VKTX Something feels odd about timing of Forbes article JPM conference and 10% haircut"
X Link 2026-01-05T20:56Z [---] followers, [----] engagements
"H.C. Wainwright bullish on Viking Therapeutics ($VKTX) after Lillys positive Phase [--] data for oral obesity drug. Maintains Buy rating with $102 PT. #Biotech #Obesity #VKTX #LLY"
X Link 2025-12-19T18:19Z [---] followers, [---] engagements
"$VKTX What will happen if a Baker Brother joins the board"
X Link 2025-11-24T21:53Z [---] followers, [---] engagements
"The Baker boys are back $VKTX"
X Link 2025-11-15T05:27Z [---] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::vtcarguy81